发明申请
US20120295842A1 PHENANTHRIDINE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
有权
苯丙胺大环内酯类抗生素C丝氨酸蛋白酶抑制剂
- 专利标题： PHENANTHRIDINE MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
- 专利标题（中）： 苯丙胺大环内酯类抗生素C丝氨酸蛋白酶抑制剂
-
申请号： US13339448申请日： 2011-12-29
-
公开(公告)号： US20120295842A1公开(公告)日： 2012-11-22
- 发明人: Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , David J. Grampovnik , Brian Green , Timothy Middleton , Todd Hopkins , Yat Sun Or
- 申请人： Keith F. McDaniel , Hui-Ju Chen , Jason P. Shanley , David J. Grampovnik , Brian Green , Timothy Middleton , Todd Hopkins , Yat Sun Or
- 主分类号： C07K7/56
- IPC分类号： C07K7/56 ; C07K1/113 ; A61P31/12 ; A61K38/12
摘要：
The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
公开/授权文献
信息查询
